Thanks for signing up for DividendStocks.com! It's the daily newsletter built for dividend and income investors. Before we can begin sending your daily updates, there’s one quick step left. Please confirm your subscription using the link below so our emails reach your inbox. Click Here to Confirm Your Subscription to DividendStocks.com Here’s a small glimpse of what you’ll get access to: Dividend Stock Ideas — Each newsletter features dividend stocks with high yields, sustainable payouts, and strong growth potential. Ex-Dividend Stocks — Want to capture upcoming dividend payouts? Find out which stocks are going ex-dividend this week. Market News and Events — Stay in the loop on the latest developments impacting popular dividend names like AT&T, Exxon Mobil, IBM, Procter & Gamble, and Verizon. Bonus: As a thank-you for confirming, you’ll also receive a free PDF copy of Automatic Income, our popular guide to building wealth through dividend investing. Let’s get your dividend journey started! Discover Top Income-Generating Stocks Here See you in your inbox soon,
The DividendStocks.com Team P.S. Don’t miss out click here to verify your subscription and secure your daily dividend insights and your free investing guide!
Featured Article from MarketBeat 3 Blue-Chip Stocks Built for a Rotating MarketWritten by Chris Markoch. Article Published: 3/8/2026. 
Key Points - Sector rotation in 2026 is favoring defensive, value-oriented areas such as utilities, healthcare, and consumer staples over mega-cap technology.
- Duke Energy and Gilead Sciences combine defensive characteristics with identifiable growth catalysts and reliable dividends.
- Hershey has rallied sharply with consumer staples, but its valuation now looks stretched relative to its earnings profile.
- Special Report: Elon Musk's $1 Quadrillion AI IPO
Sector rotation occurs when investors move money out of sectors that look overbought and into ones that seem undervalued. In 2026, that shift has tended to move capital away from mega-cap technology names and into value-oriented, defensive sectors such as energy and consumer staples. The key issue is valuation. Big tech ran hot for more than two years, largely driven by enthusiasm around artificial intelligence (AI). Despite worries about a repeat of the dot-com era, many investors largely overlooked lofty valuations. But valuation matters—eventually. As the economy shows signs of heating up, investors are seeking value elsewhere. That has put blue-chip defensive names, like the stocks below, in focus. Utilities Provide Stability in a Rotating Market Duke Energy (NYSE: DUK) is a logical beneficiary of sector rotation. Duke is a large utility provider in the Southeast and Midwest United States. Utilities stocks are among the most defensive equities and are typically viewed as value and income plays. Duke offers an attractive, reliable dividend that yields about 3.2%, and the company has raised its payout for 20 consecutive years. The changing U.S. energy landscape also opens potential growth opportunities for DUK. The company takes an "all of the above" approach to generation, including nuclear, hydroelectric and natural gas. Natural gas has helped drive the stock's strong bounce in 2026. But it's Duke's steady revenue base from its residential utility business, along with projected growth in areas such as data centers, that make DUK a target for investors rotating into defensive names. DUK is up nearly 12% in 2026, putting the stock within about 5% of its consensus price target of $136.87, which would push it above its 52-week high. Trading at roughly 20.5x earnings, the stock sits at a slight premium to its historical average. Since the company reported earnings in February, analysts have raised price targets based on expectations of strong year-over-year (YOY) revenue growth in the second half of the year. That could produce a bullish re-rating. Biotech Strength Gives Gilead Defensive Growth Analysts expect biotechnology stocks to benefit from the current rotation. Gilead Sciences (NASDAQ: GILD) provides defensive growth among healthcare stocks, a sector that has generally lagged the broader market. Gilead is a leading provider of HIV therapies, with key drugs protected by patents into the 2030s. Investors are also encouraged by the company's pipeline of more than 50 candidates. Beyond HIV, Gilead expects to launch anito-cel, a CAR-T therapy for multiple myeloma, in 2026. The company may also see a label expansion for its breast cancer drug, Trodelvy. GILD is up nearly 18% in 2026, reaching a 52-week high before pulling back slightly. That pullback may simply reflect profit-taking after an outsized run and could create a buy-the-dip opportunity. Analysts carry a consensus price target of $156.72 on GILD, implying upside of more than 8%. Since the February earnings report, many analysts have raised targets, with the highest calls around $170. Gilead also pays a dependable dividend, yielding about 2.28%, and the company has increased its payout for 10 consecutive years. Consumer Staples Rally Lifts Hershey Stock The Hershey Company (NYSE: HSY) is among the biggest beneficiaries of the rotation into consumer staples stocks in 2026. HSY is up nearly 25% this year and has broken out of a bearish trend that began in 2023. Earlier, the company faced pressure from higher cocoa costs that extended into 2025. Those headwinds are expected to continue to weigh on earnings in 2026, but the market prices in future improvements, which is part of Hershey's growth narrative. Analysts forecast stronger earnings and revenue growth later in the year. HSY is trading above its consensus price target of $222.21. Still, since the company's February earnings report, analysts have been raising targets—the most bullish view comes from Goldman Sachs, which has a $267 target. In the earnings report, Hershey increased its dividend by 5.9%, marking 15 consecutive years of hikes for a company that pays a dividend yield of about 2.5% and an annual payout of $5.81 per share. Following the recent rally, HSY now trades at more than 50x earnings. That elevated multiple likely prompted significant institutional selling last quarter, but it could also offer investors an opportunity to buy on a pullback. | 
